Relx Plc

Description

Founded in 1993, Relx Plc is a UK-based international information and analytics company that offers scientific, technical, and medical information and analytics, decision-making tools, legal information and analytics and organize exhibitions to professional and business customers. It serves customers across over 180 nations and has operations in 40 countries. The company is listed on the London Stock Exchange as LON: REL, Amsterdam Stock Exchange as Euronext Amsterdam: REN and New York Exchange as NYSE: RELX. It is a constituent of FTSE 100 Index, Euronext 100 Index and Financial Times Global 500.

The company help researchers make new discoveries, lawyers develop wining strategies and doctors & nurses improve the lives of patients. Further, it also helps in preventing online fraud and money laundering and help insurance firms in evaluating and predicting risk. The company’s powerful global technology platforms that combine leading content and data sets includes Leading content & data sets, deep customer understanding, sophisticated analytics, and technology capabilities.

The company mainly operates through four market segments that includes risk, legal, exhibitions and scientific, technical & medical. The risk segment offers customers with information-based analytics and decision tools that aims to help them in evaluating and predicting risk and increase operational efficiency by combining public and industry specific content with advanced technology and algorithms. Legal segment offers legal, regulatory, and business information and analytics to enhance decision making, productivity and achieve better outcomes.

The Exhibition segment is engaged in combining industry expertise with data and digital tools to help customers learn about market, customers connect digitally and face-to-face, source products and complete transactions. The Scientific, technical & medical segment is engaged in helping healthcare and researchers advance science and improve health by facilitating insights and critical decision-making and it also helps government and universities to evaluate and improve their research strategies.